| Detected | Trial | Change |
|---|---|---|
| 2026-05-28 | NCT06914479 Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for… |
date change Primary completion moved earlier: 2031-06-01 -> 2031-05 |
| 2026-05-28 | NCT06914479 Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for… |
date change Completion moved earlier: 2031-06-01 -> 2031-05 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-19 | NCT07597902 SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05550194 | VZV in the Enteric Nervous System: Pathogenesis and Consequences | Achalasia | Recruiting |
| Phase 3 | |||
| NCT05446571 | Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus… | Pregnant Women | Recruiting |
| Phase 2 | |||
| NCT05536349 | Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for… | Leukemia | Recruiting |
| NCT07363031 | Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy | Oral Mucositis | Enrolling by Invitation |
| NCT00492050 | Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia | Waldenstrom's Macroglobulinemia | Active, Not Recruiting |
| NCT07597902 | SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction | Post-acute Sequelae of COVID-19 | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07346144 | Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma | Glioblastoma (GBM) | Recruiting |
| Phase 1 | |||
| NCT06914479 | Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for… | Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant | Recruiting |